Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News iRhythm Technologies Inc IRTC

iRhythm Technologies, Inc. is a digital health care company, which creates solutions that detect, predict, and prevent disease. The Company designs, develops, and commercializes device-based technology to provide ambulatory cardiac monitoring services. It offers three Zio System options: the Zio Monitor System, the Zio XT System, and the Zio AT System. It offers its Zio ambulatory cardiac... see more

Recent & Breaking News (NDAQ:IRTC)

iRhythm Technologies to Report Fourth Quarter and Full Year 2022 Financial Results on February 23, 2023

GlobeNewswire February 9, 2023

iRhythm Technologies Shares Preliminary Fourth Quarter 2022 Highlights and Business Update at the 41st Annual J.P. Morgan Healthcare Conference

GlobeNewswire January 9, 2023

iRhythm® Technologies to Present at the 41st Annual J.P. Morgan Healthcare Conference

GlobeNewswire December 27, 2022

Results of Four Studies Demonstrating Clinical, Economic Value of iRhythm's Product Portfolio Presented at American Heart Association '22

GlobeNewswire November 7, 2022

New Research Confirms that Zio® by iRhythm Provides High Value From a Health Economic Perspective

GlobeNewswire November 6, 2022

iRhythm® Technologies Comments on the Final Medicare Physician Fee Schedule Released by the Centers for Medicare and Medicaid Services for Calendar Year 2023

GlobeNewswire November 2, 2022

iRhythm® Technologies Comments on the Announcement of the Medicare Physician Fee Schedule Final Rule Released by the Centers for Medicare and Medicaid Services for Calendar Year 2023

GlobeNewswire November 2, 2022

iRhythm Technologies Announces Third Quarter 2022 Financial Results

GlobeNewswire November 1, 2022

iRhythm Technologies to Report Third Quarter 2022 Financial Results on November 1, 2022

GlobeNewswire October 20, 2022

iRhythm Technologies Details Growth Strategies at 2022 Analyst & Investor Day

GlobeNewswire September 21, 2022

iRhythm Technologies to Host Analyst & Investor Day on September 21, 2022

GlobeNewswire August 31, 2022

iRhythm Technologies Announces Second Quarter 2022 Financial Results

GlobeNewswire August 4, 2022

iRhythm Technologies to Present at the Canaccord Genuity 42nd Annual Growth Conference

GlobeNewswire July 28, 2022

iRhythm Technologies Announces the Addition of Two Executive Leaders to Advance Strategic Growth and Operational Excellence

GlobeNewswire July 25, 2022

iRhythm Gains FDA Clearance for its Clinically Integrated ZEUS System

GlobeNewswire July 22, 2022

iRhythm Technologies Announces Chief Commercial Officer Transition and Schedules Second Quarter Earnings Release and Conference Call for August 4, 2022

GlobeNewswire July 18, 2022

iRhythm® Technologies Comments on the Proposed Medicare Physician Fee Schedule Released by the Centers for Medicare and Medicaid Services for Calendar Year 2023

GlobeNewswire July 8, 2022

iRhythm Technologies to Present at the 42nd Annual William Blair Growth Stock Conference

GlobeNewswire May 25, 2022

iRhythm Technologies Announces First Quarter 2022 Financial Results

GlobeNewswire May 5, 2022

iRhythm Technologies Announces Hiring of Dr. Mintu Turakhia as Chief Medical Officer and Chief Scientific Officer

GlobeNewswire April 28, 2022
USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse